Result : 5

Epidemiology of classical Hodgkin lymphoma

Classical Hodgkin lymphoma is a rare neoplasia but represents one of the most common cancers in adults younger than 40 years old. Epidemiology of Hodgkin lymphoma remains fascinating with specific...
 Hervé Ghesquières. September 2023, page 25

A better understanding of biological mechanisms

 Hervé Ghesquières. September 2023, page 29

Diagnosis and staging of Hodgkin lymphoma

Hodgkin lymphoma (HL) is composed of two distinct disease entities: classical HL (cHL) and nodular lymphocyte predominant HL (NLPHL). NLPHL is a rare entity with a specific therapeutic management....
 Hervé Ghesquières. September 2023, page 31

Challenges of long-term follow up for Hodgkin lymphoma survivors

Challenge of Hodgkin lymphoma care is to obtain a high level of curability and minimize acute toxicities and long-term complications of chemotherapy and radiotherapy. A specific long-term...
 Hervé Ghesquières. September 2023, page 53

Hodgkin lymphoma: 10 key messages

 Hervé Ghesquières. September 2023, page 73